NCT06801834 2026-03-19
EVOKE-SCLC-04
Gilead Sciences
Phase 3 Recruiting
Clinical Trials
5 trialsNCT07425795 2026-02-23
Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer
Chongqing University Cancer Hospital
Phase 2 Recruiting
NCT07063407 2025-07-14
Phase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung Cancer
Hansoh BioMedical R&D Company
Phase 1 Not yet recruiting
NCT06853678 2025-03-03
Second-line Immunotherapy for ES-SCLC
Tianjin Medical University Cancer Institute and Hospital
Phase NA Recruiting
NCT06052423 2024-03-04
ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer
Hansoh BioMedical R&D Company
Phase 2 Withdrawn